An emergency approval of one to three Covid-19 vaccines is likely in the coming months UBS Asset Management predicted on Wednesday, a milestone that could finally end the surge of mega-cap U.S. tech stocks.
UBS AM sees ’emergency’ vaccine approval in fourth quarter, hot tech to cool
